Diagnostic Performance of the Pluslife MiniDock MTB and Molbio MTB Ultima Assays to Detect Tuberculosis From Tongue and Sputum Swabs Among Outpatients and in Active Case Finding in Cameroon
Clinical Infectious Diseases · 02.09.2026 · 83 (2) · e370-e378
DOI: 10.1093/cid/ciaf709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 23.12.2025. Verfasst von Cyrille Mbuli und 24 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health Promotion and Research, Bamenda, Cameroon. Hauptthemen laut MEDLINE: Sputum, Mycobacterium tuberculosis, Tongue, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Global Affairs Canada.
Abstract (Originalsprache)
Background
Cost and infrastructure requirements limit access to current rapid molecular diagnostic testing for tuberculosis (TB). Recent developments in novel, swab-based assays that can be used closer to the point of care offer the potential to change the TB diagnostic landscape.
Methods
We assessed the diagnostic accuracy of 2 tests, Molbio Truenat MTB Ultima (MTB Ultima) and Pluslife MiniDock MTB Test (MiniDock MTB), among consecutively enrolled individuals aged 15 years and older, against the reference standard of culture and comparators of microscopy and Xpert MTB/RIF Ultra. Two tongue swabs, either self-collected or healthcare worker collected, and 2 sputum specimens were requested from each participant; MiniDock MTB was tested the same day and MTB Ultima was tested after storage.
Results
From February to June 2025, 1097 participants were enrolled in communities (382) and at health facilities (715). Sensitivities of sputum and tongue swabs on MiniDock MTB among 132 people with culture-positive TB were 86% (95% confidence interval [CI], 79–91) and 76% (95% CI, 68–82), respectively, and 67% (95% CI, 51–79) and 44% (29–59) among those with smear-negative TB. Sensitivities of sputum and tongue swabs on MTB Ultima were 84% (97/116; 95% CI, 76–89) and 74% (67/91; 95% CI, 64–82), respectively, and 58% (95% CI, 41–74) and 33% (95% CI, 18–53) among those with smear-negative TB.
Conclusions
In this population, the performance of both MiniDock MTB and MTB Ultima on tongue and sputum swabs was similar to target product profile thresholds for near point-of-care TB tests. Further studies to evaluate performance in diverse populations and settings are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Health Promotion and Research, Bamenda, Cameroon.
- Bamenda Regional Hospital, Bamenda, Cameroon.
- Cameroon Baptist Convention Health Services, Bamenda, Cameroon.
- National TB Program-Littoral Region, Douala, Cameroon.
- National TB Program-Northwest Region, Bamenda, Cameroon.
- National TB Program-Far North Region, Maroua, Cameroon.
ORCID-Profile: Cyrille Mbuli, Jean Bosco Taya-Fokou, Rita Nsamenang, Nestor Biatu, Gildas Nguimfack, Ngha Ndze Mbuh, Joceline Konso, Zourriyah Adamou Mana, Arthur Rausmis Nankouo-Njouonang, Magdalene Tiamuh, Norah Nyah Ndi, Irene Adeline Goupeyou Wandji, Maurice Ganava, Paul Meoto, Comfort Vuchas, Teyim Pride Mbuh, Valerie Flore Donkeng-Donfack, Tushar Garg, Jacob Creswell, Melissa Sander
Förderung
- Global Affairs Canada
Zitieren
APA
Mbuli, C., Taya-Fokou, J. B., Nsamenang, R., Biatu, N., Nguimfack, G., Ndze Mbuh, N., Konso, J., Adamou Mana, Z., Nankouo-Njouonang, A. R., Tiamuh, M., Nsame, D., Ndi, N. N., Goupeyou Wandji, I. A., Fundoh, M., Ganava, M., Bello, O., Meoto, P., Fitame, A., Vuchas, C., …, & RAPID TB Consortium (2026). Diagnostic Performance of the Pluslife MiniDock MTB and Molbio MTB Ultima Assays to Detect Tuberculosis From Tongue and Sputum Swabs Among Outpatients and in Active Case Finding in Cameroon. Clinical Infectious Diseases, 83(2), e370-e378. https://doi.org/10.1093/cid/ciaf709
Vancouver
Mbuli C, Taya-Fokou JB, Nsamenang R, Biatu N, Nguimfack G, Ndze Mbuh N, et al. Diagnostic Performance of the Pluslife MiniDock MTB and Molbio MTB Ultima Assays to Detect Tuberculosis From Tongue and Sputum Swabs Among Outpatients and in Active Case Finding in Cameroon. Clinical Infectious Diseases. 2026;83(2):e370-e378. doi:10.1093/cid/ciaf709
BibTeX
@article{Mbuli2026,
author = {Mbuli, Cyrille and Taya-Fokou, Jean Bosco and Nsamenang, Rita and Biatu, Nestor and Nguimfack, Gildas and Ndze Mbuh, Ngha and Konso, Joceline and Adamou Mana, Zourriyah and Nankouo-Njouonang, Arthur Rausmis and Tiamuh, Magdalene and Nsame, Denis and Ndi, Norah Nyah and Goupeyou Wandji, Irene Adeline and Fundoh, Mercy and Ganava, Maurice and Bello, Ousmanou and Meoto, Paul and Fitame, Adeline and Vuchas, Comfort and Mbuh, Teyim Pride and Donkeng-Donfack, Valerie Flore and Garg, Tushar and Creswell, Jacob and Sander, Melissa and RAPID TB Consortium, RAPID TB Consortium},
title = {Diagnostic Performance of the Pluslife MiniDock MTB and Molbio MTB Ultima Assays to Detect Tuberculosis From Tongue and Sputum Swabs Among Outpatients and in Active Case Finding in Cameroon},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {83},
number = {2},
pages = {e370--e378},
doi = {10.1093/cid/ciaf709}
}
EUVIMED